484 related articles for article (PubMed ID: 24997608)
1. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice.
Oh DY; Walenta E; Akiyama TE; Lagakos WS; Lackey D; Pessentheiner AR; Sasik R; Hah N; Chi TJ; Cox JM; Powels MA; Di Salvo J; Sinz C; Watkins SM; Armando AM; Chung H; Evans RM; Quehenberger O; McNelis J; Bogner-Strauss JG; Olefsky JM
Nat Med; 2014 Aug; 20(8):942-7. PubMed ID: 24997608
[TBL] [Abstract][Full Text] [Related]
2. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects.
Oh DY; Talukdar S; Bae EJ; Imamura T; Morinaga H; Fan W; Li P; Lu WJ; Watkins SM; Olefsky JM
Cell; 2010 Sep; 142(5):687-98. PubMed ID: 20813258
[TBL] [Abstract][Full Text] [Related]
3. Involvement of G-Protein-Coupled Receptor 40 in the Inhibitory Effects of Docosahexaenoic Acid on SREBP1-Mediated Lipogenic Enzyme Expression in Primary Hepatocytes.
On S; Kim HY; Kim HS; Park J; Kang KW
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31142011
[TBL] [Abstract][Full Text] [Related]
4. GPR120 protects lipotoxicity-induced pancreatic β-cell dysfunction through regulation of PDX1 expression and inhibition of islet inflammation.
Wang Y; Xie T; Zhang D; Leung PS
Clin Sci (Lond); 2019 Jan; 133(1):101-116. PubMed ID: 30523046
[TBL] [Abstract][Full Text] [Related]
5. GPR120 agonists for the treatment of diabetes: a patent review (2014 present).
Zhang X; Macielag MJ
Expert Opin Ther Pat; 2020 Oct; 30(10):729-742. PubMed ID: 32799609
[TBL] [Abstract][Full Text] [Related]
6. In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice.
Shewale SV; Brown AL; Bi X; Boudyguina E; Sawyer JK; Alexander-Miller MA; Parks JS
J Lipid Res; 2017 Jan; 58(1):236-246. PubMed ID: 27811230
[TBL] [Abstract][Full Text] [Related]
7. Omega 3 fatty acids and GPR120.
Oh DY; Olefsky JM
Cell Metab; 2012 May; 15(5):564-5. PubMed ID: 22560206
[TBL] [Abstract][Full Text] [Related]
8. Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice: a role for GPR120 in glucagon secretion.
Suckow AT; Polidori D; Yan W; Chon S; Ma JY; Leonard J; Briscoe CP
J Biol Chem; 2014 May; 289(22):15751-63. PubMed ID: 24742677
[TBL] [Abstract][Full Text] [Related]
9. The beneficial effects of n-3 polyunsaturated fatty acids on diet induced obesity and impaired glucose control do not require Gpr120.
Bjursell M; Xu X; Admyre T; Böttcher G; Lundin S; Nilsson R; Stone VM; Morgan NG; Lam YY; Storlien LH; Lindén D; Smith DM; Bohlooly-Y M; Oscarsson J
PLoS One; 2014; 9(12):e114942. PubMed ID: 25541716
[TBL] [Abstract][Full Text] [Related]
10. Diabetes: Gpr120 agonist has anti-inflammatory and insulin-sensitizing effects.
Greenhill C
Nat Rev Endocrinol; 2014 Sep; 10(9):510. PubMed ID: 25048034
[No Abstract] [Full Text] [Related]
11. Biological characteristics and agonists of GPR120 (FFAR4) receptor: the present status of research.
Li A; Li Y; Du L
Future Med Chem; 2015; 7(11):1457-68. PubMed ID: 26230883
[TBL] [Abstract][Full Text] [Related]
12. FFAR4 (GPR120) Signaling Is Not Required for Anti-Inflammatory and Insulin-Sensitizing Effects of Omega-3 Fatty Acids.
Pærregaard SI; Agerholm M; Serup AK; Ma T; Kiens B; Madsen L; Kristiansen K; Jensen BA
Mediators Inflamm; 2016; 2016():1536047. PubMed ID: 27999451
[TBL] [Abstract][Full Text] [Related]
13. Positive interplay between FFAR4/GPR120, DPP-IV inhibition and GLP-1 in beta cell proliferation and glucose homeostasis in obese high fat fed mice.
Owolabi AI; Corbett RC; Flatt PR; McKillop AM
Peptides; 2024 Jul; 177():171218. PubMed ID: 38621590
[TBL] [Abstract][Full Text] [Related]
14. A novel GPR120-selective agonist promotes insulin secretion and improves chronic inflammation.
Yang L; Lei XT; Huang Q; Wang T; Sun HB; Wang HY
Life Sci; 2021 Mar; 269():119029. PubMed ID: 33450256
[TBL] [Abstract][Full Text] [Related]
15. Unsaturated fatty acids from flaxseed oil and exercise modulate GPR120 but not GPR40 in the liver of obese mice: a new anti-inflammatory approach.
Gaspar RC; Veiga CB; Bessi MP; Dátilo MN; Sant'Ana MR; Rodrigues PB; de Moura LP; da Silva ASR; Santos GA; Catharino RR; Ropelle ER; Pauli JR; Cintra DE
J Nutr Biochem; 2019 Apr; 66():52-62. PubMed ID: 30771734
[TBL] [Abstract][Full Text] [Related]
16. Insulinotropic effects of GPR120 agonists are altered in obese diabetic and obese non-diabetic states.
Zhang D; So WY; Wang Y; Wu SY; Cheng Q; Leung PS
Clin Sci (Lond); 2017 Feb; 131(3):247-260. PubMed ID: 27980130
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of GPR120 signaling in intestine ameliorates insulin resistance and fatty liver under high-fat diet feeding.
Yasuda T; Harada N; Hatoko T; Ichimura A; Ikeguchi-Ogura E; Murata Y; Wada N; Kiyobayashi S; Yamane S; Hirasawa A; Inagaki N
Am J Physiol Endocrinol Metab; 2023 May; 324(5):E449-E460. PubMed ID: 37074989
[TBL] [Abstract][Full Text] [Related]
18. GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy.
Satapati S; Qian Y; Wu MS; Petrov A; Dai G; Wang SP; Zhu Y; Shen X; Muise ES; Chen Y; Zycband E; Weinglass A; Di Salvo J; Debenham JS; Cox JM; Lan P; Shah V; Previs SF; Erion M; Kelley DE; Wang L; Howard AD; Shang J
J Lipid Res; 2017 Aug; 58(8):1561-1578. PubMed ID: 28583918
[TBL] [Abstract][Full Text] [Related]
19. Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer.
Liang P; Henning SM; Guan J; Grogan T; Elashoff D; Olefsky JM; Cohen P; Aronson WJ
J Natl Cancer Inst; 2019 Jan; 111(1):52-59. PubMed ID: 30202902
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation.
Yan Y; Jiang W; Spinetti T; Tardivel A; Castillo R; Bourquin C; Guarda G; Tian Z; Tschopp J; Zhou R
Immunity; 2013 Jun; 38(6):1154-63. PubMed ID: 23809162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
